Do Invalid HBsAg/anti-HBc/anti-HTLV-I/II ChLIA Results Follow Through to Subsequent Donations?

被引：0
|
作者：
Kiely, N. [1 ]
Kamel, H. [1 ]
Tomasulo, P. A. [1 ]
Roesler, P. [2 ]
机构：
[1] Blood Syst, Scottsdale, AZ USA
[2] Creat Testing Solut, Tempe, AZ USA
来源：
TRANSFUSION | 2011年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：205A / 206A
页数：2
相关论文
共 44 条
  • [21] Second Chances: Donor Management with the PRISM Anti-HTLV-I/II Screening Assay
    Nguyen, K. T.
    TRANSFUSION, 2010, 50 : 5A - 5A
  • [22] EPIDEMIOLOGY OF ANTI-HTLV-I/II ANTIBODIES IN FRENCH BLOOD-DONORS POPULATION
    LEMAIRE, JM
    COSTE, J
    BARIN, F
    COUROUCE, AM
    REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (01): : 21 - 34
  • [23] REEVALUATION OF ANTI-HTLV-I WESTERN-BLOT ASSAY USING HTLV-I AND HTLV-II SERUM PANELS
    FUJIYAMA, C
    FUJIYOSHI, T
    MATSUMOTO, D
    YASHIKI, S
    TAMASHIRO, H
    SONODA, S
    CLINICAL AND DIAGNOSTIC VIROLOGY, 1995, 4 (02): : 149 - 161
  • [24] EVALUATION OF 8 SEROLOGICAL TESTS TOR ANTI-HTLV-I AND ANTO-HTLV-II ANTIBODIES DETECTION
    ICARDI, GC
    GABUTTI, G
    WICKS, R
    GAINO, M
    DELLAPIETRA, P
    CROVARI, P
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 496 - 496
  • [25] Isolated anti-HBc antibodies in a paediatric population in Turkey: prevalence and follow-up results
    Ertekin, V
    Selimoglu, MA
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (10) : 1075 - 1076
  • [26] Epidemiological study in blood donors positive and negative antibodies anti-HTLV-I/II.
    Cesar, MA
    Nukui, Y
    Tatsui, NH
    Mota, MA
    Perina, EF
    Saezalquezar, A
    Bucheri, V
    DorlhiacLlacer, PE
    Chamone, DF
    Cliquet, MG
    BLOOD, 1996, 88 (10) : 3086 - 3086
  • [27] Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance covering 50 million donations in Germany
    Houareau, C.
    Preussel, K.
    Ritter, S.
    Offergeld, R.
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2017, 44 : 18 - 18
  • [28] INVESTIGATION OF ANTI-HTLV-I/II SEROPREVALENCE IN HEALTHY BLOOD DONORS IN IZMIR REGION, TURKEY
    Sertoz, Ruchan
    Turhan, Ajda
    Bozkurt, Hale
    Samlioglu, Pinar
    Degirmencl, Aysu
    Aydinok, Yesim
    Erensoy, Selda
    MIKROBIYOLOJI BULTENI, 2010, 44 (04): : 579 - 584
  • [29] EVALUATION OF A COMBINED LYSATE/RECOMBINANT ANTIGEN ANTI-HTLV-I/II ELISA IN HIGH AND LOW ENDEMIC AREAS OF HTLV-I/II INFECTION
    VRIELINK, H
    SISAY, Y
    REESINK, HW
    WOERDEMAN, M
    WINKEL, C
    DELEEUW, SJ
    LELIE, PN
    VANDERPOEL, CL
    TRANSFUSION MEDICINE, 1995, 5 (02) : 135 - 137
  • [30] LYMPHOCYTE IMMUNOPHENOTYPES AMONG ANTI-HTLV-I/-II-POSITIVE BLOOD-DONORS AND RECIPIENTS
    FLETCHER, MA
    GJERSET, GF
    HASSETT, J
    DONEGAN, E
    PARKER, JW
    MOSLEY, JW
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (06): : 628 - 632
12345